LEPTIN - ANVISA Registration 10338930208
Access comprehensive regulatory information for LEPTIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930208 and manufactured by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DRG INTERNATIONAL, INC., DRG INSTRUMENTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10338930208
25351428434201859
93741726000166
Company Information
Dates and Status
Feb 18, 2019
VIGENTE
09/18/2025 19:00:01
LEPTINA
DRG LEPITINA โ ELISA
DRG INTERNATIONAL, INC.
80680420084
May 29, 2023
LEPTINA
Leptin ELISA
LDN- LABOR DIAGNOSTIKA NORD GMBH & CO, KG
81086830054
Feb 06, 2023
LEPTINA
Leptin Sandwich ELISA
DRG INTERNATIONAL, INC.
10230730176
Jan 16, 2023
LEPTINA
Leptina ELISA
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
10338930269
Sep 09, 2021
LEPTINA
LEPTIN
DIAGNOSTICS BIOCHEM CANADA INC
10300390556
May 20, 2019

